AG
TLC

Advisor Group’s Taiwan Liposome Company, Ltd. American Depository Shares TLC Stock Holding History

Advisor Group’s Portfolio TLC Stock Details TLC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Hold
500
– – ﹤0.01% 4919
2019
Q3 		$3K Hold
500
– – ﹤0.01% 4909
2019
Q2 		$3K Buy
500
+300
+150% +$1.68K ﹤0.01% 4916
2019
Q1 		$1K Buy
+200
New +$1.23K ﹤0.01% 5155

Other funds holding TLC

KPC
Karst Peak Capital Hong Kong $8.61M AUM 270.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HR
Howe & Rusling Rochester, New York $1.72B AUM 25.63% 1-Year Est. Return

Advisor Group's TLC Position: Q4 2019 in Review

Advisor Group held its Taiwan Liposome Company, Ltd. American Depository Shares (TLC) position steady in Q4 2019 at 500 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4919.

Advisor Group first reported a position in TLC in Q1 2019 and has held it in 4 quarters since. 6 funds tracked by Wall St. Rank hold TLC as of Q4 2019.

  • Advisor Group held 500 shares of Taiwan Liposome Company, Ltd. American Depository Shares worth $3K as of Q4 2019.
  • Advisor Group left its Taiwan Liposome Company, Ltd. American Depository Shares share count unchanged in Q4 2019.
  • Taiwan Liposome Company, Ltd. American Depository Shares made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4919 holding.
  • Advisor Group first reported a position in Taiwan Liposome Company, Ltd. American Depository Shares in Q1 2019 and has held it in 4 quarters since.
  • 6 funds tracked by Wall St. Rank held Taiwan Liposome Company, Ltd. American Depository Shares as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.